Maximum Daily Puffs for Flutiform 125 and 250
The maximum recommended dose is 2 puffs twice daily (4 puffs total per day) for both Flutiform 125/5 µg and 250/10 µg strengths.
Dosing Framework
While the provided evidence does not contain specific FDA labeling for Flutiform (fluticasone propionate/formoterol fumarate), the dosing follows standard ICS/LABA combination therapy principles established in asthma guidelines.
Standard Dosing by Strength
Flutiform 125/5 µg:
- Standard dose: 2 puffs twice daily (total daily dose: 250 µg fluticasone/10 µg formoterol)
- This represents a low-to-medium ICS dose range 1
Flutiform 250/10 µg:
- Standard dose: 2 puffs twice daily (total daily dose: 500 µg fluticasone/20 µg formoterol)
- This represents a medium-to-high ICS dose range 1
Clinical Evidence Supporting This Dosing
The research evidence consistently demonstrates that fluticasone/formoterol is studied and effective at twice-daily dosing:
- Clinical trials used 2 puffs twice daily as the standard regimen for both 100/10 µg, 250/10 µg, and 500/20 µg strengths 2, 3, 4
- Studies in pediatric populations (ages 5-12) also used 2 puffs twice daily of the 100/10 µg strength 5
- Real-world effectiveness studies confirm this dosing provides adequate asthma control with acceptable safety profiles 6, 7, 8
Important Caveats
Do not exceed 4 puffs per day (2 puffs twice daily) without specialist consultation. Higher doses of ICS beyond medium-range doses (>500 µg fluticasone equivalent daily) provide minimal additional benefit but significantly increase the risk of systemic adverse effects including adrenal suppression, osteoporosis, and Cushing syndrome 1.
If asthma control is inadequate at maximum doses, the appropriate response is to step up therapy by adding additional controller medications (such as leukotriene modifiers or tiotropium) or referring to a specialist, rather than exceeding the recommended maximum dose 1.
The dose-response relationship for ICS demonstrates that 80-90% of maximum therapeutic benefit is achieved at relatively low doses (200-250 µg fluticasone equivalent daily), with diminishing returns and increasing adverse effects at higher doses 9.